Prasugrel for Japanese patients with acute coronary syndrome in short-term clinical practice (PRASFIT-Practice I): a postmarketing observational study

Data on prasugrel use in Japanese patients are limited to phase II/III clinical trials. This early postmarketing observational study evaluated the safety and efficacy of short-term prasugrel use in patients with acute coronary syndrome (ACS) in real-world clinical settings in Japan. From May 2014 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Masato, Iizuka, Tomoko, Sagawa, Kei, Abe, Kenji, Chikada, Shuichi, Arai, Miyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880844/
https://www.ncbi.nlm.nih.gov/pubmed/28213685
http://dx.doi.org/10.1007/s12928-017-0459-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880844/
https://www.ncbi.nlm.nih.gov/pubmed/28213685
http://dx.doi.org/10.1007/s12928-017-0459-8

Ejemplares similares